Trial · NCT03047863
Therapeutic Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors
NCT03047863, Not applicable, Unknown, The Catholic University of Korea
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Therapeutic Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors. Trials, record NCT03047863. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03047863
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Therapeutic Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors
- NCT number
- NCT03047863
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 20 participants, estimated
- Lead sponsor
- The Catholic University of Korea
- Conditions
- Drug-Related Side Effects and Adverse Reactions, Epidermal Growth Factor
- Interventions
- Repair Control EGF®, Cream without rhEGF
- First posted
- 2017-02-09
- Last updated
- 2017-02-10
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The change of severity of acneform eruption induced by EGFR inhibitors | Baseline, 1 week, 2 weeks, 4 weeks | To evaluate the severity of acneiform eruption, the investigators take a photograph of full face. The number of inflammatory and noninflammatory lesions will be counted and accessed the severity based on the Korean Acne Grading System(KAGS). |
| Secondary | change of skin hydration | Baseline, 1 week, 2 weeks, 4 weeks | Skin hydration is measured with Corneometer® (CM820/825; C-K Electronics, Cologne, Germany). It shows the skin moisturizing condition in arbitrary units(AU) and the unit is from 0 to 220. |
| Secondary | change of sebum production | Baseline, 1 week, 2 weeks, 4 weeks | Sebum production is measured with Sebumeter® (SM815; C-K Electronics, Cologne, Germany). It measured at forehead, cheek and chin, presented as ㎍/㎠. |
| Secondary | Investigator's global assessment score | Baseline, 1 week, 2 weeks, 4 weeks | Investigator's global assessment (IGA) Score : It will be assessed as a 5-point scale (-1 = worsen, to 3 = marked improvement). |
| Secondary | Patient's global assessment score | Baseline, 1 week, 2 weeks, 4 weeks | Patient's global assessment (PGA) score will be assessed as a 5-point scale (-1 = worsen, to 3 =marked improvement). |
| Secondary | The side effects of product | Baseline, 1 week, 2 weeks, 4 weeks | It will be assessed by patient-report. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03047863
GET https://conductscience.org/api/trials/v1/NCT03047863/registered